MeSH tree: D12.776.124.790.651.114.224.060.438
Nearly 10,000 cases of advanced bowel cancer are diagnosed in England each year, with cases in young adults rising. There are limited options for treating advanced bowel cancer. Scientists have now developed an AI-powered ...
Apr 14, 2026
0
10
A study published April 10 in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) significantly improved overall survival in adults with platinum-resistant ovarian cancer when given as ...
Apr 13, 2026
0
5
Results from a pilot clinical trial evaluating the safety and feasibility of repeated focused ultrasound-induced blood–brain barrier (BBB) opening combined with the monoclonal antibody drug Avastin (bevacizumab) in patients ...
Feb 3, 2026
0
7
Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical ...
Dec 12, 2025
0
19
Retinal vein occlusion (RVO) is one of the leading causes of vision loss worldwide, often triggered by chronic diseases such as hypertension and diabetes. Similar to a blocked water pipe causing backflow and pressure buildup, ...
Oct 29, 2025
0
12
University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.
Jul 25, 2025
0
19
An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively and at a much lower cost than many existing treatments, an initial clinical trial suggests. Further, ...
May 27, 2025
0
50
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...
May 12, 2025
0
13
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a "master regulator" gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving ...
Apr 3, 2025
0
20
A study led by Roswell Park Comprehensive Cancer Center provides new insight into the complex interactions of the "tumor-immune-gut axis," and its role in influencing immunotherapy responses in patients with recurrent ovarian ...
Dec 13, 2024
0
50
